Dynacin Related Published Studies
Well-designed clinical trials related to Dynacin (Minocycline)
Effect of minocycline on lumbar radicular neuropathic pain: a randomized,
placebo-controlled, double-blind clinical trial with amitriptyline as a
comparator. [2015]
Effect of Minocycline on Lumbar Radicular Neuropathic Pain: A Randomized,
Placebo-controlled, Double-blind Clinical Trial with Amitriptyline as a
Comparator. [2014]
Impact of minocycline on cerebrospinal fluid markers of oxidative stress,
neuronal injury, and inflammation in HIV-seropositive individuals with cognitive
impairment. [2014]
Minocycline supplementation for treatment of negative symptoms in early-phase
schizophrenia: a double blind, randomized, controlled trial. [2014]
Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study
protocol for a double-blind randomized placebo-controlled trial. [2013]
High MMP-9 activity levels in fragile X syndrome are lowered by minocycline. [2013]
A randomized double-blind, placebo-controlled trial of minocycline in children
and adolescents with fragile x syndrome. [2013]
Minocycline benefits negative symptoms in early schizophrenia: a randomised
double-blind placebo-controlled clinical trial in patients on standard treatment. [2012]
Results of a phase II placebo-controlled randomized trial of minocycline in acute
spinal cord injury. [2012]
Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. [2011.10]
Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. [2011.09.20]
Clinical and biochemical efficacy of minocycline in nonsurgical periodontal therapy: a randomized controlled pilot study. [2011.06]
Non-surgical periodontal therapy with and without subgingival minocycline administration in patients with poorly controlled type II diabetes: a randomized controlled clinical trial. [2011.03.18]
A randomised controlled trial assessing the effect of adding clarithromycin to rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India. [2011.03]
Treatment of postinfectious olfactory disorders with minocycline: a double-blind, placebo-controlled study. [2011.03]
Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem. [2011.02]
Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. [2011.01]
A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration. [2011]
[Evaluation years in leprosy patients treated with single dose alternative scheme ROM (rifampin, ofloxacin, minocycline), after seven to nine]. [2010.11]
Open-label add-on treatment trial of minocycline in fragile X syndrome. [2010.10.11]
A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. [2010.02]
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). [2010.01.15]
Association of antimicrobial and clinical efficacy: periodontitis therapy with minocycline microspheres. [2010.01]
A double-blind, randomized study of minocycline for the treatment of negative and
cognitive symptoms in early-phase schizophrenia. [2010]
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial. [2009.10]
Glatiramer Acetate in Combination with Minocycline in Patients with Relapsing-Remitting Multiple Sclerosis: Results of a Canadian, Multicenter, Double-Blind, Placebo-Controlled Trial. [2009.09.23]
Bioequivalence study of two minocycline capsule formulations in healthy volunteers. [2009]
Local minocycline as an adjunct to surgical therapy in moderate to severe, chronic periodontitis. [2008.06]
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. [2007.12.01]
Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study. [2007.05.01]
Effect of treatment of rosacea in females by Chibixiao Recipe in combination with minocycline and spironolactone. [2006.12]
Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. [2006.10]
Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. [2006.05]
Topical minocycline microspheres versus topical chlorhexidine gel as an adjunct to mechanical debridement of incipient peri-implant infections: a randomized clinical trial. [2006.05]
Additional minocycline pleurodesis after thoracoscopic surgery for primary spontaneous pneumothorax. [2006.03.01]
A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. [2006.03]
Longitudinal clinical evaluation of adjunct minocycline in the treatment of chronic periodontitis. [2006.02]
Supportive periodontal therapy using mechanical instrumentation or 2% minocycline gel: a 12 month randomized, controlled, single masked pilot study. [2006.02]
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection. [2006.01]
Minocycline in amyotrophic lateral sclerosis: a pilot study. [2005.10]
A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. [2005.06]
Efficacy of subgingivally applied minocycline in the treatment of chronic periodontitis. [2005.02]
Well-designed clinical trials possibly related to Dynacin (Minocycline)
Measuring disease progression in early Parkinson disease: the National Institutes
of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. [2014]
Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan. [2011.04]
Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam
in the treatment of complicated skin and skin structure infections in patients
from India and Taiwan. [2011]
Tigecycline population pharmacokinetics in patients with community- or hospital-acquired pneumonia. [2010.12]
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia. [2010.10]
Assessing the minimally important difference in the oral impact on daily performances index in patients treated for periodontitis. [2010.10]
A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections. [2010.08]
Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. [2010.07.21]
Tooth discoloration of immature permanent incisor associated with triple antibiotic therapy: a case report. [2010.06]
Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. [2010.05]
In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for diabetic foot infections. [2010.04]
Reduction of PrP(C) in human cerebrospinal fluid after spinal cord injury. [2010.04]
[Therapeutic effects of three topical remedies on periodontitis] [2010.03]
Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. [2010.02]
Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials. [2010.01.15]
Safety and efficacy of intravenous tigecycline in subjects with secondary
bacteremia: pooled results from 8 phase III clinical trials. [2010]
[Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia in children undergoing chemotherapy and hematopoietic stem cell transplantation] [2009.12]
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia. [2009.09.09]
Effect of antimicrobial periodontal treatment and maintenance on serum adiponectin in type 2 diabetes mellitus. [2009.02]
Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin. [2009.01]
Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience. [2008.10]
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective. [2008.10]
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections - the European experience. [2008.10]
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. [2008.09]
Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia. [2008.07]
Serological response to chemoprophylaxis in extended contacts in leprosy--a randomized controlled trial. [2008.02]
Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections. [2008.01]
Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. [2008]
Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials. [2007.12]
Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials. [2007.10.17]
Infection reduction using antibiotic-coated inflatable penile prosthesis. [2007.08]
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections. [2007.06]
Predictors of efficacy and health resource utilization in treatment of complicated intra-abdominal infections: evidence for pooled clinical studies comparing tigecycline with imipenem-cilastatin. [2007.04]
A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy. [2006.03]
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. [2005.11]
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]. [2005.10.19]
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. [2005.09.01]
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial. [2005.09]
Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. [2005.08]
Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. [2005.03]
Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens. [2005.01]
Combined effects of Nd:YAG laser irradiation with local antibiotic application into periodontal pockets. [2005.01]
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. [2005.01]
Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. [2005.01]
Other research related to Dynacin (Minocycline)
Intrapleural minocycline pleurodesis for the treatment of primary spontaneous
pneumothorax. [2014]
Minocycline improves peripheral and autonomic neuropathy in type 2 diabetes: MIND
study. [2014]
Electrocortical changes associated with minocycline treatment in fragile X
syndrome. [2013]
Prospective, randomized, open-label trial comparing the safety, efficacy, and
tolerability of an acne treatment regimen with and without a probiotic supplement
and minocycline in subjects with mild to moderate acne. [2013]
Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg
oral minocycline plus 15% azelaic acid in the treatment of acne rosacea. [2013]
Simple aspiration and drainage and intrapleural minocycline pleurodesis versus
simple aspiration and drainage for the initial treatment of primary spontaneous
pneumothorax: an open-label, parallel-group, prospective, randomised, controlled
trial. [2013]
Minocycline for acne vulgaris: efficacy and safety. [2012]
The effects of pregabalin and the glial attenuator minocycline on the response to
intradermal capsaicin in patients with unilateral sciatica. [2012]
Efficacy of minocycline in acute ischemic stroke: a single-blinded,
placebo-controlled trial. [2012]
Cryotherapy and topical minocycline as adjunctive measures to control pain after third molar surgery: an exploratory study. [2011.11]
Does minocycline, an antibiotic with inhibitory effects on microglial activation, sharpen a sense of trust in social interaction? [2011.09.29]
Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis. [2011.09.13]
Life-threatening complications related to minocycline pleurodesis. [2011.09]
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. [2011.09]
Minocycline Development for Acute Ischemic Stroke. [2011.06.01]
|